Seattle, WA4 Active Studies

Parkinsons Disease Clinical Trials in Seattle, WA

Find 4 actively recruiting parkinsons disease clinical trials in Seattle, WA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
10,241
Enrolling

Recruiting Parkinsons Disease Studies in Seattle

About Parkinsons Disease Clinical Trials in Seattle

Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.

There are currently 4 parkinsons disease clinical trials recruiting participants in Seattle, WA. These studies are seeking a combined 10,241 participants. Research is being sponsored by University of Washington, Boston Scientific Corporation, Immune Oncology Research Institute and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Parkinsons Disease Clinical Trials in Seattle — FAQ

Are there parkinsons disease clinical trials in Seattle?

Yes, there are 4 parkinsons disease clinical trials currently recruiting in Seattle, WA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Seattle?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Seattle research site will contact you about next steps.

Are clinical trials in Seattle free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Seattle studies also compensate for your time and travel.

What parkinsons disease treatments are being tested?

The 4 active trials in Seattle are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.

Data updated September 7, 2026 from ClinicalTrials.gov